Literature DB >> 21391686

Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.

Brian M Zeglis1, Vadim Divilov, Jason S Lewis.   

Abstract

The topoisomerase-IIα inhibition and antiproliferative activity of α-heterocyclic thiosemicarbazones and their corresponding copper(II) complexes have been investigated. The Cu(II)(thiosemicarbazonato)Cl complexes were shown to catalytically inhibit topoisomerase-IIα at concentrations (0.3-7.2 μM) over an order of magnitude lower than their corresponding thiosemicarbazone ligands alone. The copper complexes were also shown to inhibit the proliferation of breast cancer cells expressing high levels of topoisomerase-IIα (SK-BR-3) at lower concentrations than cells expressing lower levels of the enzyme (MCF-7).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391686      PMCID: PMC4151564          DOI: 10.1021/jm101532u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.

Authors:  J Easmon; G Heinisch; W Holzer; B Rosenwirth
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

Review 2.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.

Authors:  Patric J Jansson; Philip C Sharpe; Paul V Bernhardt; Des R Richardson
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

4.  The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.

Authors:  V Ashutosh Rao; Sarah R Klein; Keli K Agama; Eriko Toyoda; Noritaka Adachi; Yves Pommier; Emily B Shacter
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides.

Authors:  D X West; A E Liberta; K G Rajendran; I H Hall
Journal:  Anticancer Drugs       Date:  1993-04       Impact factor: 2.248

6.  Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity.

Authors:  Paul V Bernhardt; Philip C Sharpe; Mohammad Islam; David B Lovejoy; Danuta S Kalinowski; Des R Richardson
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

7.  A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells.

Authors:  Brigette Ma; Boon Cher Goh; Eng Huat Tan; Kwok Chi Lam; Ross Soo; Swan Swan Leong; Ling Zhi Wang; Frankie Mo; Anthony T C Chan; Benny Zee; Tony Mok
Journal:  Invest New Drugs       Date:  2007-09-12       Impact factor: 3.850

8.  The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells.

Authors:  Junnan Chen; Yue-wern Huang; Guanshu Liu; Zahra Afrasiabi; Ekkehard Sinn; Subhash Padhye; Yinfa Ma
Journal:  Toxicol Appl Pharmacol       Date:  2004-05-15       Impact factor: 4.219

9.  Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.

Authors:  L A Saryan; E Ankel; C Krishnamurti; D H Petering; H Elford
Journal:  J Med Chem       Date:  1979-10       Impact factor: 7.446

10.  Antineoplastic and Cytotoxic Activities of Nickel(II) Complexes of Thiosemicarbazones.

Authors:  I H Hall; M C Miller; D X West
Journal:  Met Based Drugs       Date:  1997
View more
  17 in total

Review 1.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

2.  A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα.

Authors:  Shayna Sandhaus; Rosella Taylor; Tiffany Edwards; Alexis Huddleston; Ykeysha Wooten; Ramaiyer Venkatraman; Ralph T Weber; Antonio González-Sarrías; Patrick M Martin; Patrice Cagle; Yuk-Ching Tse-Dinh; Stephen J Beebe; Navindra Seeram; Alvin A Holder
Journal:  Inorg Chem Commun       Date:  2016-02       Impact factor: 2.495

3.  Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex.

Authors:  Fatemeh Ghorbani Parsa; Mohammad Ali Hosseinpour Feizi; Reza Safaralizadeh; Seyed Abolfazl Hosseini-Yazdi; Majid Mahdavi
Journal:  J Biol Inorg Chem       Date:  2020-04-09       Impact factor: 3.358

4.  Design and synthesis of novel N()-substituted thiosemicarbazones bearing a pyrrole unit as potential anticancer agents.

Authors:  Taofeng Zhu; Shanshan Shen; Qin Lu; Xingpei Ye; Weiliang Ding; Ruhua Chen; Jing Xie; Wenjiao Zhu; Jun Xu; Lei Jia; Weina Wu; Tieliang Ma
Journal:  Oncol Lett       Date:  2017-04-05       Impact factor: 2.967

5.  Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.

Authors:  Roya Salehi; Selda Abyar; Fatemeh Ramazani; Ali Akbar Khandar; Seyed Abolfazl Hosseini-Yazdi; Jonathan M White; Mahdi Edalati; Houman Kahroba; Mehdi Talebi
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

6.  Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.

Authors:  Pierre Daumar; Brian M Zeglis; Nicholas Ramos; Vadim Divilov; Kuntal Kumar Sevak; NagaVaraKishore Pillarsetty; Jason S Lewis
Journal:  Eur J Med Chem       Date:  2014-09-08       Impact factor: 6.514

7.  Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration.

Authors:  Biao Hu; Bo Wang; Bing Zhao; Qian Guo; Zhong-Hua Li; Xin-Hui Zhang; Guang-Yao Liu; Ying Liu; Ying Tang; Fan Luo; Ya Du; Ya-Xin Chen; Li-Ying Ma; Hong-Min Liu
Journal:  Medchemcomm       Date:  2017-10-23       Impact factor: 3.597

8.  Substituted N-aminothioglycolurils containing thiosemicarbazone moiety and their cytotoxic activity in vitro.

Authors:  Galina A Gazieva; Lada V Anikina; Sergei A Pukhov; Tatyana B Karpova; Yulia V Nelyubina; Angelina N Kravchenko
Journal:  Mol Divers       Date:  2016-05-23       Impact factor: 2.943

9.  Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.

Authors:  Anna Gatti; Abraha Habtemariam; Isolda Romero-Canelón; Ji-Inn Song; Bindy Heer; Guy J Clarkson; Dominga Rogolino; Peter J Sadler; Mauro Carcelli
Journal:  Organometallics       Date:  2018-02-20       Impact factor: 3.876

10.  G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound.

Authors:  Maia Cabrera; Natalia Gomez; Federico Remes Lenicov; Emiliana Echeverría; Carina Shayo; Albertina Moglioni; Natalia Fernández; Carlos Davio
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.